Kawasaki Diseases usually affects young children under the age of five. In a new article, Dr. Rebong explains the symptoms, treatments and precautions.

Kenneth Pomar Rebong, MD (N/A:N/A)

SAN JOSE, CALIFORNIA, UNITED STATES, June 7, 2019 /EINPresswire.com/ -- Kawasaki Disease, also known as Mucocutaneous Lymph Node Disease, is a rare illness that typically strikes children younger than 5. Estimates indicate that at least 3,000 cases are diagnosed each year in the US. This disease is especially common in children of Japanese and Korean descent. It is one of the prime causes of heart diseases in infants because of complications.

Dr. Kenneth Rebong has published an overview article on this condition. The complete article will be published on the Blog of Dr. Rebong at https://drkennethrebong.wordpress.com/

If diagnosed and treated on time, Kawasaki can be controlled and minimum impact occurs. However, if the condition is not acknowledged on time, it mostly leads to complications like heart diseases and Reye’s disease, which ultimately lead to death. If treatment begins at the early stages of the disease, most of the children usually end up recovering completely. Fortunately, most children affected by Kawasaki disease recover without any complications or chronic diseases.

This condition involves problems of the mouth, skin, heart, nose throat, and lymph nodes. Kawasaki disease typically targets children under the age of five. When an adolescent is suffering from the Kawasaki disease, the blood vessels in his entire body become inflamed. This inflammation leads to coronary artery damage since blood cannot be transported to the heart as efficiently as it used to. This eventually leads to death of the patient.

The exact cause of the disease is still unknown; however, researchers claim that Kawasaki is potentially linked to genetics. Hereditary factors are also claimed to be responsible for the disease. They believe that this disease is probably related to a combination of different genetic material, viral and bacterial exposures, toxins and irritant chemicals and substances.

Symptoms

Symptoms of the Kawasaki disease consists of high fever of around 101 degrees Fahrenheit and above, rashes and peeling skin, redness and swelling, gland enlargement, throat irritation, “strawberry tongue,” joint pain and stomach troubles. The disease, however, is not contagious.

Diagnosis and Treatment

Kawasaki disease is diagnosed by a traditional physical examination where conclusions are drawn based on the symptoms displayed. However, treatment can be quite extensive depending on the condition’s progression. Early treatment can save lives.

Treatment includes administering gamma globulin (purified antibodies) via intravenous (IV) doses to help prepare the body to further fight against the infection. Other steps include high aspirin doses to lower the risk of potential heart diseases. On the other hand, precautionary measures just include a single, very vital step, which is getting regular flu jabs to prevent viral infections when aspirin doses are being administered so as to avoid Reye’s disease.

Most of the children suffering from Kawasaki disease start showing improvements from the first time the treatments are provided. In order to avoid complications and fatalities, it is very important to consult a doctor as soon as any of the symptoms related to Kawasaki start to appear.

About Dr. Kenneth Pomar Rebong

Dr. Kenneth P. Rebong, a medical doctor in San Jose, California, specializes in Pediatrics and Adolescent Medicine. The scope of his practice is from age 0 to 21. He graduated from FEUNRMF University in Manila, Philippines and completed his residency at Rutgers University in New Brunswick, New Jersey, USA.

Blog: https://drkennethrebong.wordpress.com/
News: https://hype.news/dr-kenneth-pomar-rebong/
https://medicogazette.com/dr-kenneth-pomar-rebong
https://hippocratesguild.com/dr-kenneth-pomar-rebong
https://www.linkedin.com/in/kenneth-pomar-rebong-md-4484a938/

Kenneth Pomar Rebong, MD
Kenneth Pomar Rebong, MD
+ + + + + + +1 408-729-3232
email us here
Visit us on social media:
LinkedIn

Kawasaki Disease: Updates for pediatric primary care providers - Michigan Medicine

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.